OPEN END TURBO BULL OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 11:09:26 25/06/2024 pm IST | ||
| 10.97 EUR | +4.28% |
|
| Current month | +14.63% | ||
| 1 month | +11.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 25/24/25 | 10.97 | +4.28% |
| 24/24/24 | 10.52 | +4.06% |
| 21/24/21 | 10.11 | +1.61% |
| 20/24/20 | 9.95 | +2.79% |
| 19/24/19 | 9.68 | +0.21% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 11:09 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC420X |
| ISIN | DE000HC420X2 |
| Date issued | 10/02/2023 |
| Strike | 202.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.03 € |
|---|---|
| Lowest since issue | 2.42 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
